Table 1.
Demographic and disease characteristics of patients who underwent full baseline assessment
| |
|
All subjects (N = 15) |
|
|
|---|---|---|---|---|
| |
|
Completed (N = 10) |
Withdrawn (N = 5) |
|
| Mean (SD) | P | |||
|
Age yrs |
67.9 (9.4) |
67.6 (10.9) |
68.4 (6.3) |
0.88 |
|
Body mass index kg/m
2
|
23.1 (4.6) |
23.7(4.9) |
22.1(4.2) |
0.52 |
| |
N (%) |
|
|
|
|
Sex | ||||
| M |
9 (60) |
4 (40) |
5 (100) |
|
| F |
6 (40) |
6 (60) |
0 (0) |
0.04 |
|
PS | ||||
| 1 |
2 (13) |
2 (20) |
0 (0) |
|
| 2 |
6 (40) |
4 (40) |
2 (40) |
|
| 3 |
7 (47) |
4 (40) |
3 (60) |
0.79 |
|
Diagnosis | ||||
| Lung cancer |
4 (27) |
3 (30) |
1 (20) |
|
| GI cancer |
6 (40) |
2 (20) |
4 (80) |
|
| Other |
5 (33) |
5 (50) |
0 (0) |
NA |
|
Cancer stage | ||||
| III |
1 (7) |
1 (10) |
0 (0) |
|
| IV |
11 (73) |
6 (60) |
5 (100) |
|
| NA |
3 (20) |
3 (30) |
0 (0) |
NA |
|
Chemotherapy | ||||
| Y |
10 (67) |
6 (60) |
4 (80) |
|
| N |
5 (33) |
4 (40) |
1 (20) |
0.60 |
|
Recent steroid use | ||||
| Y |
6 (40) |
4 (40) |
2 (40) |
|
| N | 9 (60) | 6 (60) | 3 (60) | 1.00 |
Notes: P indicates result of significance testing (unpaired t-test for means or Fisher’s exact test for count data) comparing patients who did, or did not, complete the study.